biotech

Personalized Vaccine Against Glioblastoma

Filed in archive Drugs, Vaccines and Therapeutics on February 6, 2007

Personalized Vaccine Against Glioblastoma
Back in November, I wrote an entry on the status of the a vaccine against gliomas, particularly on glioblastoma multiforme. The vaccine, prepared by the biotech firm Antigenics from the patient's own tumor, has elicited immune response in all 12 patients under Phase I clinical trials.
After a tumor is surgically removed it's immediately shipped to Antigenics [snip]. Lab scientists homogenize and extract a particular compound of immune-boosting protein peptides that carries the DNA fingerprint of the patient's cancer. It is isolated and purified into individualized vaccine vials.

Antigenics has released a video accompanying the ABC news report.

Permalink: Personalized Vaccine Against Glioblastoma

Tags: vaccine  glioma  glioblastoma  biotech  against  vaccine+against  against+glioblastoma  personalized+vaccin 

Vote for Personalized Vaccine Against Glioblastoma:

  • Currently 7.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 7.00 out of 5 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Most Popular   Best of   Biotech Hubs and Facilities   Biotech/Science Blogs   Corporate and Industrial News   Diagnostics, Methodologies and Instrumentation   Did you know   Drugs, Vaccines and Therapeutics   Energy, Environment and Ecology   Food and Agriculture   Gene Therapy   Genomics, Proteomics and Bioinformatics   Information About   Meetings and Other Events   Microbiology   Misc   Nanomedicine   Other Biotechnology News   Patents and Intellectual Property Rights   Quick introduction   Stem Cells